Nicholas Investment Partners, LP Vera Therapeutics, Inc. Transaction History
Nicholas Investment Partners, LP
- $804 Million
- Q1 2025
A detailed history of Nicholas Investment Partners, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 95,402 shares of VERA stock, worth $1.99 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
95,402
Previous 106,805
10.68%
Holding current value
$1.99 Million
Previous $4.52 Million
49.27%
% of portfolio
0.28%
Previous 0.5%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$119 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.9 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$61 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $565M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...